Stay updated on JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial
Sign up to get notified when there's something new on the JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial page.

Latest updates to the JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedUpdates appear to be minor (formatting changes and timestamp updates) with no impact on core study content such as eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedUpdated to v3.2.0 with an operational status notice and added medical term; removed the previous version tag v3.1.0.SummaryDifference3%

- Check44 days agoChange DetectedVersion bump to v3.1.0 with removal of the term 'Diffuse large b-cell lymphoma', indicating a scope reduction or reclassification of content rather than a substantive new addition.SummaryDifference0.2%

- Check59 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the Back to Top element; overall, this is a minor maintenance/UI update with no impact on core content, pricing, stock, or time slots.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe webpage has been updated to include new drug information and research studies related to Lisocabtagene Maraleucel, while removing some previous location and genetic resource details.SummaryDifference8%

Stay in the know with updates to JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial page.